Join
Live feed
·
INSIDERFilingvia Quantisnow
Beta Bionics Inc. logo

Director Lezack Adam sold $9,950 worth of shares (1,000 units at $9.95) as part of a pre-agreed trading plan, was granted 16,965 shares and sold $11,188 worth of Comon Stock (998 units at $11.21) as part of a pre-agreed trading plan, increasing direct ownership by 120% to 27,399 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BBNX (Beta Bionics Inc.) and more on Quantisnow.